
Atherothrombosis
Discover more on science updates, events, KOLs interviews and more on Atherothrombosis
Science in Atherothrombosis
Get a 360º view and stay up-to-date on Atherothrombosis with content selected for you

- Atherothrombosis
Ticagrelor vs Clopidogrel in ACS patients undergoing PCI in routine clinical practice
.jpg/jcr:content/jcr_content%20(22).jpg)
- Atherothrombosis
In hospital outcomes in young patients with AMI: Results from Gulf Coast
.jpg/jcr:content/jcr_content%20(20).jpg)
- Atherothrombosis
Effect of de-escalated P2Y12 inhibitor switching in dual antiplatelet therapy (DAPT)
.jpg/jcr:content/jcr_content%20(18).jpg)
- Atherothrombosis
Is Clopidogrel a viable first choice P2Y12 inhibitor for DAPT after PCI?
Inspiration and innovation
Get inspired and stay at the forefront of innovation with the following resources

- Atherothrombosis
Ticagrelor vs Clopidogrel in ACS patients undergoing PCI in routine clinical practice
.jpg/jcr:content/jcr_content%20(22).jpg)
- Atherothrombosis
In hospital outcomes in young patients with AMI: Results from Gulf Coast
.jpg/jcr:content/jcr_content%20(20).jpg)
- Atherothrombosis
Effect of de-escalated P2Y12 inhibitor switching in dual antiplatelet therapy (DAPT)
.jpg/jcr:content/jcr_content%20(18).jpg)
- Atherothrombosis